Genetic ablation of p16 mitigates premature osteoporosis induced by PTHrP nuclear localization sequence and C-terminal deletion through inhibition of cellular senescence
Stem Cells · 2025
DOI: 10.1093/stmcls/sxae088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells, 2025. Verfasst von Yongli Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Changzhou Hygiene Vocational Technology College, Changzhou 213000, China. Hauptthemen laut MEDLINE: Cellular Senescence, Parathyroid Hormone-Related Protein, Osteoporosis, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Premature osteoporosis caused by parathyroid hormone-related peptide (PTHrP) dysfunction presents significant bone health challenges. The role of p16-mediated cellular senescence in this condition remains unclear.
Methods
Using a Pthrp knock-in (KI) mouse model lacking the nuclear localization sequence and C-terminus of PTHrP, we generated p16⁻⁄⁻KI mice and compared them with wild-type, p16⁻⁄⁻, and KI mice. We analyzed survival, skeletal phenotypes, bone marrow mesenchymal stem cell (BM-MSC) function, and molecular markers of senescence.
Results
Genetic ablation of p16 in KI mice extended their lifespan, increased body size and weight, and improved skeletal growth. Micro-CT analysis revealed significantly increased bone volume, while histological studies showed enhanced chondrocyte proliferation and osteoblast function in p16⁻⁄⁻KI mice compared to KI mice. In vitro experiments demonstrated enhanced differentiation capacity and reduced senescence of BM-MSCs from p16⁻⁄⁻KI mice, as evidenced by increased colony formation and osteogenic marker expression. Molecular analyses indicated that p16 knockout partially reversed oxidative stress, DNA damage, and cellular senescence observed in KI mice, shown by upregulated antioxidant enzymes, reduced DNA damage markers, and decreased senescence markers. Conclusions: p16-mediated cellular senescence plays a crucial role in premature osteoporosis caused by PTHrP dysfunction. Targeting cellular senescence pathways may offer a promising therapeutic strategy for treating premature osteoporosis and age-related bone loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nursing, Changzhou Hygiene Vocational Technology College, Changzhou 213000, China.
- The Research Center for Bone and Stem Cells, Department of Anatomy, Histology and Embryology, Nanjing Medical University, Nanjing 211166, China.
- Department of Orthopedics, Children's Hospital of Nanjing Medical University, Nanjing 210008, China.
ORCID-Profile: Dengshun Miao
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
Zitieren
APA
Han, Y., Qiao, W., Xue, Q., Miao, D., & Dong, Z. (2025). Genetic ablation of p16 mitigates premature osteoporosis induced by PTHrP nuclear localization sequence and C-terminal deletion through inhibition of cellular senescence. Stem Cells. https://doi.org/10.1093/stmcls/sxae088
Vancouver
Han Y, Qiao W, Xue Q, Miao D, Dong Z. Genetic ablation of p16 mitigates premature osteoporosis induced by PTHrP nuclear localization sequence and C-terminal deletion through inhibition of cellular senescence. Stem Cells. 2025. doi:10.1093/stmcls/sxae088
BibTeX
@article{Han2025,
author = {Han, Yongli and Qiao, Wanxin and Xue, Qi and Miao, Dengshun and Dong, Zhan},
title = {Genetic ablation of p16 mitigates premature osteoporosis induced by PTHrP nuclear localization sequence and C-terminal deletion through inhibition of cellular senescence},
journal = {Stem Cells},
year = {2025},
doi = {10.1093/stmcls/sxae088}
}
EUVIMED